Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 3/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | HRH1 | P35367 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azasetron SCHEMBL19492326 | 1.00 | HTR3A (1.00) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL17191 | 1.00 | HTR3A (1.00) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL13186328 | 1.00 | HTR3A (1.00) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL29880168 | 1.00 | HTR3A (1.00) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL19463750 | 1.00 | HTR3A (1.00) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL1023863 | 0.99 | HTR3A (0.98) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL442156 | 0.99 | HTR3A (0.98) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL29089146 | 0.98 | HTR3A (0.96) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL1649657 | 0.98 | HTR3A (0.96) | HTR3AKCNH2HTR2ASLC6A4HRH1 | |
| Azasetron SCHEMBL19463074 | 0.94 | HTR3A (0.89) | HTR3AKCNH2HTR2ASLC6A4HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10866 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144776-A1 | COMBINATION THERAPY FOR A DOPAMINE AGONIST | ALTO NEUROSCIENCE, INC. (US) | 2026-05-28 | — | — | US | claimed |
| EP-4739318-A1 | AZASETRON FOR THE PRESERVATION OF RESIDUAL HEARING FOLLOWING COCHLEAR IMPLANTATION | Sensorion (FR) | 2026-05-13 | — | — | EP | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| EP-3615024-B1 | COMPOSITIONS COMPRISING PRAMIPEXOLE AND A 5HT3 ANTAGONIST FOR USE IN TREATING DEPRESSION | ALTO NEUROSCIENCE INC (US) | 2026-02-18 | — | — | EP | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20250222003-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING SOLID TUMORS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-07-10 | — | — | US | claimed |
| US-20250170139-A1 | AZASETRON FOR THE TREATMENT OF SUDDEN SENSORINEURAL HEARING LOSS | SENSORION (FR) | 2025-05-29 | — | — | US | claimed |
| WO-2025077727-A1 | USE OF PEPTIDE AMIDE COMPOUND IN PREPARATION OF DRUG FOR PREVENTING NAUSEA AND VOMITING | 海思科医药集团股份有限公司 | 2025-04-17 | — | — | WO | claimed |
| WO-2025008371-A1 | AZASETRON FOR THE PRESERVATION OF RESIDUAL HEARING FOLLOWING COCHLEAR IMPLANTATION | SENSORION (FR) | 2025-01-09 | — | — | WO | claimed |
| CN-109259908-B | Novel drug-loaded airway stent and preparation method thereof | 广州医科大学 | 2024-12-31 | — | — | CN | claimed |
| EP-0975327-A1 | USE OF 5HT3 ANTAGONISTS FOR PROMOTING INTESTINAL LAVAGE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-02-02 | — | — | EP | claimed |
| WO-1999017755-A2 | MEDICAMENTS | GLAXO GROUP LIMITED (GB) | 1999-04-15 | — | — | WO | claimed |
| CN-1201390-A | 5-HT3 receptor antagonists for treating dyskinesia | GLAXO WELLCOME INC (GB) | 1998-12-09 | — | — | CN | claimed |
| WO-1998047481-A1 | USE OF 5HT3 ANTAGONISTS FOR PROMOTING INTESTINAL LAVAGE | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-10-29 | — | — | WO | claimed |
| EP-0851756-A1 | 5-HT 3? RECEPTOR ANTAGONISTS FOR DYSKINESIA | GLAXO GROUP LIMITED (GB) | 1998-07-08 | — | — | EP | claimed |
| WO-1997047285-A1 | GASTRIC-RETENTIVE ORAL CONTROLLED DRUG DELIVERY SYSTEM WITH ENHANCED RETENTION PROPERTIES | DEPOMED, INC. (US) | 1997-12-18 | — | — | WO | claimed |
| WO-1997010823-A1 | 5-HT3 RECEPTOR ANTAGONISTS FOR DYSKINESIA | GLAXO GROUP LIMITED (GB) | 1997-03-27 | — | — | WO | claimed |
| EP-0313393-B1 | Benzoxazine compounds and pharmaceutical use thereof | YOSHITOMI PHARMACEUTICAL (JP) | 1994-03-16 | — | — | EP | claimed |
| US-4892872-A | ANTIEMETICS, ANTINAUSEA | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1990-01-09 | — | — | US | claimed |
| EP-0313393-A2 | Benzoxazine compounds and pharmaceutical use thereof | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1989-04-26 | — | — | EP | claimed |